By Zach Stanley, Executive Director, Bioversity

One of the main findings from MassBio’s 2022 Life Sciences Workforce Analysis report was that the existing educational and workforce training ecosystem in Massachusetts was not equipped to supply enough trained life sciences talent to meet employer demand in the coming years. With the expectation at the time of tens of thousands of new people needed to fill a variety of entry and non-entry level roles, it was unclear where all the talent would come from to keep Massachusetts’ leading ecosystem at the top of its game.

Flash forward to 2025, and oof, the outlook is not as optimistic. The biotech industry is shrinking. There are fewer biotech job postings and at the same time companies are shrinking. In the first half of 2025, there were 128 layoff rounds by U.S. biotech companies – a 32% increase from 2024, according to Fierce Biotech.

So, why is Bioversity growing at the same time as the biotech industry is shrinking?

Read the rest of this blog as originally posted on massbio.org